EBV based cancer prevention and therapy in nasopharyngeal carcinoma.

EBV based cancer prevention and therapy in nasopharyngeal carcinoma.
复制标题

基于EBV的鼻咽癌预防和治疗

DOI:
10.1038/s41698-017-0018-x
复制
发表时间:
2017
影响因子:
7.9
通讯作者:
Cao Y
Cao Y
中科院分区:
医学1区
文献类型:
--
作者:
Cao Y

文献摘要

参考文献

被引文献

相似文献

爱泼斯坦-巴尔病毒是一种重要的致癌病毒。鼻咽癌是一种由Epstein-Barr病毒强烈驱动的感染相关性癌症。在这个肿瘤模型中,我们确定了潜伏膜蛋白1的主要宿主靶点,潜伏膜蛋白1是EB病毒在潜伏感染过程中编码的一个驱动癌基因。潜伏膜蛋白1激活多个致癌信号轴,导致多种恶性表型和治疗耐药。此外,爱泼斯坦-巴尔病毒上调DNA甲基转移酶1,并在癌症发生中介导肿瘤表观遗传效应。潜伏膜蛋白1激活的协同作用通路构成了致癌信号网络,使潜伏膜蛋白1成为有效治疗或预防干预的重要潜在靶点。在EB病毒裂解期,血浆EB病毒DNA水平被认为是鼻咽癌在健康高危人群中的鉴别标志,也是EB病毒阳性鼻咽癌的新的预后标志。目前,裂解蛋白和EB病毒DNA的早期检测和筛查已应用于临床和高危人群。产生的关于Epstein-Barr病毒的知识可以在不久的将来用于基于Epstein-Barr病毒的精确癌症预防和治疗。
Epstein–Barr virus is an important cancer causing virus. Nasopharyngeal carcinoma is an infection-related cancer strongly driven by Epstein–Barr virus. In this cancer model, we identified the major host targets of latent membrane protein 1 which is a driving oncogene encoded by Epstein–Barr virus in latency infection. latent membrane protein 1 activates several oncogenic signaling axes causing multiple malignant phenotypes and therapeutic resistance. Also, Epstein–Barr virus up-regulates DNA methyltransferase 1 and mediates onco-epigenetic effects in the carcinogenesis. The collaborating pathways activated by latent membrane protein 1 constructs an oncogenic signaling network, which makes latent membrane protein 1 an important potential target for effective treatment or preventive intervention. In Epstein–Barr virus lytic phase, the plasma level of Epstein–Barr virus DNA is considered as a distinguishing marker for nasopharyngeal carcinoma in subjects from healthy high-risk populations and is also a novel prognostic marker in Epstein–Barr virus-positive nasopharyngeal carcinoma. Now the early detection and screening of the lytic proteins and Epstein–Barr virus DNA have been applied to clinical and high-risk population. The knowledge generated regarding Epstein–Barr virus can be used in Epstein–Barr virus based precision cancer prevention and therapy in the near future.
潜伏膜蛋白 1 表达对 Epstein-Barr 病毒相关癌症总体生存的影响:基于文献的荟萃分析
DOI: 10.18632/oncotarget.4906
发表时间: 2015-10-06
期刊: Oncotarget
影响因子: --
作者:
Chen YP;Zhang WN;Chen L;Tang LL;Mao YP;Li WF;Liu X;Zhou GQ;Sun Y;Kang TB;Zeng MS;Liu N;Ma J
通讯作者: Ma J
DOI: 10.1007/s12011-011-9135-5
发表时间: 2011-12-01
影响因子: 3.9
作者:
Gargouri, Bochra;Nasr, Rihab;Van Pelt, Jos
通讯作者: Van Pelt, Jos
DOI: 10.1016/j.coviro.2014.02.005
发表时间: 2014-06
影响因子: 5.9
作者:
Balfour, Henry H., Jr.
通讯作者: Balfour, Henry H., Jr.
DOI: 10.1002/rmv.1758
发表时间: 2013-11
影响因子: 11.1
作者:
Hoebe, Eveline K.;Le Large, Tessa Y. S.;Greijer, Astrid E.;Middeldorp, Jaap M.
通讯作者: Middeldorp, Jaap M.
DOI: 10.1084/jem.20070256
发表时间: 2007-08-06
期刊: The Journal of experimental medicine
影响因子: --
作者:
Hislop AD;Ressing ME;van Leeuwen D;Pudney VA;Horst D;Koppers-Lalic D;Croft NP;Neefjes JJ;Rickinson AB;Wiertz EJ
通讯作者: Wiertz EJ